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Editorial
The news that the Editorial Board of the Australian Journal 
of Physiotherapy is moving to require that trials submitted 
for publication provide evidence of prospective registration 
in a publicly-accessible register is welcome as it indicates 
that specialist journals are now following the lead of the 
International Committee of Medical Journal Editors. In 
September 2004, the Committee decreed that from 1 July 
2005 all trials submitted for publication in the world’s major 
medical journals must have registered key details of the 
trial’s design in a publicly-accessible register before the first 
participant was enrolled (DeAngelis et al 2004).
Reasons
Why have these journal editors, and now the Editorial 
Board of the Australian Journal of Physiotherapy, taken 
this position, ie, why is the prospective registration of trials 
important? The Declaration of Helsinki (World Medical 
Association 1964), established after World War II to protect 
the rights of human research subjects, states that the design 
of all studies should be publicly available. Despite this, we 
now know that the results of a substantial proportion of 
studies are not published at all (Dickersin and Rennie 2003). 
Making clinical or policy decisions based on only a subset 
of the complete evidence-base can result in very different 
conclusions being drawn (Simes 1986). This ‘publication 
bias’ can have serious consequences as the recent exposure 
of incomplete reporting of drug trials has highlighted 
(Jureidini et al 2004, Whittington et al 2004). In the wake 
of such scandals, researchers have, perhaps not surprisingly, 
recently felt the force of increasing public mistrust in their 
activities (Godlee 2005, Martinson et al 2005). One way in 
which trust could be enhanced would be for the public to be 
reassured that the existence and main design features of all 
trials were disclosed at their inception, and that these details 
were kept permanently on record. In doing so, it would be 
possible to compare what researchers initially planned to do 
with what they ultimately reported and published.
In addition to enhancing public trust in research, there are 
many other reasons to encourage prospective trial registration. 
If clinicians and potential participants are able to identify 
studies that are currently open to recruitment there may 
well be increased participation in trials. Funders would also 
benefit by being able to direct resources to areas identified 
as having a limited evidence base. Those who summarise 
research results, including authors of systematic reviews and 
practice guidelines, would benefit greatly from being able 
to identify quickly and unambiguously all trials that have 
been undertaken in their area of interest—whether they had 
been published or not. Overall, increasing transparency and 
accountability in the research process through prospective 
trial registration will benefit everyone—clinicians, funders, 
policy makers, researchers, and the public alike.
A related problem is the so-called ‘selective reporting of 
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outcomes’ where, although a study’s findings are published, 
only selected results are reported, often those favouring the 
investigational drug or new treatment (Chan et al 2004). 
Trial registration in its current form will not solve this 
problem completely as trialists need only to disclose key 
(not all) primary and secondary outcomes. However, there 
is the potential to extend the remit of trial registration in the 
future to also include the lodging of a full protocol (either 
in public or in escrow) at a trial’s inception (Krlezˇa-Jeric´ 
et al 2005). This would enable people to compare the full 
details of what researchers said they had planned to do at the 
start of a trial with what they ultimately published and made 
available to the public.
In light of the recent enthusiasm for trial registration, it 
will be important to co-ordinate global activities related to 
this initiative if we are to prevent a plethora of regional or 
disease-based registries with duplicate information. Such 
a situation might make searching for specific information 
more, rather than less, difficult. To that end, the World Health 
Organization (WHO) has taken the lead in establishing the 
International Clinical Trials Registry Platform which aims 
to form a worldwide network of high-quality trial registers. 
The main objective is to facilitate a single point-of-access 
portal which will enable the unambiguous identification 
of trials by searching across the worldwide network of 
registers. Work is well under way to achieve this goal.
Requirements
Australia has played, and will continue to play, a leading role 
in these worldwide trials registration activities. The major 
recent initiative was the establishment, in July 2005, of the 
online Australian Clinical Trials Registry (www.actr.org.
au). Australians now have a place where they can register 
their studies as well as find out about clinical trial activity 
in our region. The Australian registery accepts studies with 
all types of designs, all types of interventions, and from all 
regions. In January 2006, the International Committee of 
Medical Journal Editors acknowledged that the Australian 
registry fulfilled their requirements for an acceptable register 
for both data and administration criteria (ICMJE 2006). 
The Australian Clinical Trials Registry is governed by a 
high-level external Advisory Board with wide stakeholder 
representation. Current funding is via a five year National 
Health and Medical Research Council Enabling Grant.
The International Committee of Medical Journal Editors 
have stated that the studies which should be registered 
include ‘all research projects which prospectively assign 
human subjects to intervention and concurrent comparison/
control groups to study the cause-and-effect relationship 
between a medical intervention and a health outcome. 
Medical interventions include any intervention used to 
modify a health outcome. This definition includes drugs, 
surgical procedures, devices, behavioural treatments, 
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process of-care changes, and the like.’ They require trials to 
be registered at, or before, enrolment of the first participant 
(DeAngelis et al 2004).
Additionally, in November 2005 the WHO International 
Clinical Trials Registry Platform recommended the 
registration of all interventional clinical trials, including 
early phase uncontrolled trials in patients or healthy 
volunteers (WHO 2005). They also state that all registration 
data items should be publicly disclosed at the time of 
registration. Certain groups, in particular the pharmaceutical 
industry, have argued that in some circumstances revealing 
information such as details of the intervention to be tested, 
may put companies at a competitive disadvantage if rivals 
know about novel new treatments before a product is ready 
for licensing. However, after extensive public consultation, 
the WHO has declared it does not support any mechanism 
for delayed disclosure of data items. Both the International 
Committee of Medical Journal Editors and WHO have 
outlined 20 specific data items as being the minimal 
information that must be provided to satisfy trial registration 
criteria (DeAngelis et al 2004, WHO 2006). These are data 
items that would enable the public to reasonably discern 
what the trial was about and include information on the 
trial’s participants, interventions, outcomes, sample size, 
funder(s), contact persons, and other design features.
The Australian Clinical Trials Registry possesses other 
features such as being searchable, free-of-charge, and 
having quality control procedures in place. Currently trial 
registration in Australia is voluntary. If registrants choose 
to register their trial on the Australian registry, they must 
provide meaningful information for each of the 20 minimum 
data items and these will all be made publicly available at the 
time of registration. ‘Meaningful information’ involves not 
just writing ‘procedure A vs procedure B’ as a description 
of the interventions being tested in the trial. Registrants 
are required to provide sufficient detail so that readers can 
understand what the trial is really about. For example, a 
meaningful description of the intervention might be ‘group 
circuit class compared to one-to-one physiotherapy’. It is 
the responsibility of the trial Sponsor to ensure the quality, 
accuracy, and currency of the data lodged on the registry. 
A trial Sponsor is defined as ‘an individual, company, 
institution or organisation that takes responsibility for the 
initiation, management and/or financing of a clinical trial.’ 
(TGA 2001). Trial Sponsors wishing to register their trial 
on the Australian registry, register as a ‘user’ and, once 
verified, are able to enter, save, and then submit their data 
for registration. The information is checked by registry 
staff for duplication, accuracy, and completeness before 
registration.
Challenges
Whilst the establishment of the Australian Clinical Trials 
Register has been an important step forward, achieving a 
complete and comprehensive system of prospective trial 
registration is not without its challenges.
One of the main challenges is ensuring that all trials are 
registered. At present, whilst the requirement of the 
International Committee of Medical Journal Editors is a 
major incentive for researchers to register their trials, the 
fact remains that trial registration in Australia is voluntary. 
Hence we have no way of knowing whether the 1200 trials 
registered on the Australian registry to date represent all, 
some, or only a small proportion of the clinical trials being 
undertaken nationally. The most effective way to ensure 
registration of all trials informing health care practice would 
be to make trials registration a condition of Ethical approval. 
We have proposed a simple mechanism for achieving this 
without increasing the workload of Ethics Committees. This 
model is currently being considered in a review of several 
key documents relating to the conduct of clinical trials in 
Australia: the National Statement (2006), the Australian 
Code for the Responsible Conduct of Research (2006) and 
the National Ethics Application Form (2006).
A related challenge is to ensure that the data submitted to 
the registry are meaningful and accurate. The Australian 
Clinical Trials Registry has quality control procedures 
in place that allow discussion with the registrant between 
data submission and prior to trial registration to clarify any 
potential errors and ensure completeness of the mandatory 
data items. If a registrant refuses to complete a mandatory 
data field with meaningful information, trial registration will 
not be permitted. Other registries, such as ClinicalTrials.gov 
(www.clinicaltrials.gov), have found that some Sponsors 
did not provide meaningful detail for some data items such 
as the primary outcome (Zarin et al 2006).
One final challenge is the task of minimising duplicate 
entries both within and across trial registers. This task is 
easier said than done. The Australian Clinical Trials Registry 
is working closely with the WHO and other major registers 
around the world to share experience and technical expertise 
to ensure that these challenges are overcome. The aim is to 
facilitate a system whereby anyone looking for trials related 
to a certain condition can access a one-stop search portal 
which will look within and across registers and provide a 
short-list of potential trials and their details within seconds.
The establishment of the Australian Clinical Trials Registry 
in 2005 has been a major milestone for trials registration in 
Australia. However, much is still to be done and we have 
plans for continuous improvement of the current facility 
including more advanced search functionality and the ability 
to update some data fields whilst still retaining the original 
dataset as registered. A comprehensive series of stakeholder 
consultations was undertaken in the latter part of 2006 to 
help identify how users would like the registry to operate 
both now and in the future.
Summary
The WHO International Clinical Trials Registry Platform 
has stated that the prospective registration of clinical trials 
is an ‘ethical, scientific and moral obligation’ for those 
undertaking research on humans. Australia has taken this 
obligation seriously with the establishment of the Australian 
Clinical Trials Registry, an online database of clinical trials 
being undertaken throughout the country that is accessible 
to all. Efforts continue to ensure that all clinical trials are 
registered at inception and that the public can be reassured 
that researchers will be transparent and accountable in 
disclosing the results of their research activities.
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Statement regarding registration of clinical trials from the 
Editorial Board of Australian Journal of Physiotherapy
This journal is moving towards requiring that clinical trials whose results are submitted for publication in Australian Journal 
of Physiotherapy are registered. From January 2008, all clinical trials submitted to the journal must have been registered 
prospectively in a publicly-accessible trials register. We will accept any register that satisfies the International Committee of 
Journal Editors requirements. Authors must provide the name and address of the register and the trial registration number on 
submission.
